Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).

Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Brooks DJ, Passmore AP, Ballard C, Edison P.

Trials. 2019 Apr 3;20(1):191. doi: 10.1186/s13063-019-3259-x.

2.

Bienfaits du tai-chi sur la santé: Quelles sont les données probantes?

Huston P, McFarlane B.

Can Fam Physician. 2016 Nov;62(11):e645-e654. Review. French.

PMID:
28661882
Free Article
3.

Health benefits of tai chi: What is the evidence?

Huston P, McFarlane B.

Can Fam Physician. 2016 Nov;62(11):881-890. Review.

4.

Investigating the Primary Care Management of Low Back Pain: A Simulated Patient Study.

Abdel Shaheed C, McFarlane B, Maher CG, Williams KA, Bergin J, Matthews A, McLachlan AJ.

J Pain. 2016 Jan;17(1):27-35. doi: 10.1016/j.jpain.2015.09.010. Epub 2015 Oct 9.

PMID:
26456675
5.

Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial.

Butchart J, Brook L, Hopkins V, Teeling J, Püntener U, Culliford D, Sharples R, Sharif S, McFarlane B, Raybould R, Thomas R, Passmore P, Perry VH, Holmes C.

Neurology. 2015 May 26;84(21):2161-8. doi: 10.1212/WNL.0000000000001617. Epub 2015 May 1. Erratum in: Neurology. 2015 Dec 8;85(23):2084.

6.

Taoist Tai Chi® and Memory Intervention for Individuals with Mild Cognitive Impairment.

Fogarty JN, Murphy KJ, McFarlane B, Montero-Odasso M, Wells J, Troyer AK, Trinh D, Gutmanis I, Hansen KT.

J Aging Phys Act. 2016 Apr;24(2):169-80. doi: 10.1123/japa.2014-0062. Epub 2015 Apr 2.

PMID:
25838271
7.

Class II correction prior to orthodontics with the carriere distalizer.

McFarlane B.

Int J Orthod Milwaukee. 2013 Fall;24(3):35-6.

PMID:
24358656
8.

Methamphetamine-induced disruption of frontostriatal reward learning signals: relation to psychotic symptoms.

Bernacer J, Corlett PR, Ramachandra P, McFarlane B, Turner DC, Clark L, Robbins TW, Fletcher PC, Murray GK.

Am J Psychiatry. 2013 Nov;170(11):1326-34. doi: 10.1176/appi.ajp.2013.12070978.

PMID:
23732871
9.

The effect of processing techniques and brine formulations on the development of surface sheen in enhanced beef strip loin steaks.

Holmer SF, McFarlane BJ, McKeith FK, Killefer J.

Meat Sci. 2011 May;88(1):151-7. doi: 10.1016/j.meatsci.2010.12.016. Epub 2010 Dec 10.

PMID:
21236587
10.

An overview and history of interpersonal psychotherapy.

Sloan G, Hobson J, Leighton J, McFarlane B, Law R.

Nurs Stand. 2009 Mar 4-10;23(26):44-9. Review.

PMID:
19323110
11.

Human dimensions of forest disturbance by insects: an international synthesis.

Flint CG, McFarlane B, Müller M.

Environ Manage. 2009 Jun;43(6):1174-86. doi: 10.1007/s00267-008-9193-4. Epub 2008 Sep 5.

PMID:
18773237
12.

Perceptions of ecological risk associated with mountain pine beetle (Dendroctonus ponderosae) infestations in Banff and Kootenay National Parks of Canada.

McFarlane BL, Watson DO.

Risk Anal. 2008 Feb;28(1):203-12. doi: 10.1111/j.1539-6924.2008.01013.x. Erratum in: Risk Anal. 2008 Jun;28(3):803. Witson, David OT [corrected to Watson, David OT].

PMID:
18304117
13.

Using expert judgments to understand spatial patterns of forest-based camping: a values-at-risk application.

Neupane A, Boxall PC, McFarlane BL, Pelletier RT.

J Environ Manage. 2007 Oct;85(2):471-82. Epub 2006 Dec 12.

PMID:
17166650
14.
15.

Public perceptions of risk to forest biodiversity.

McFarlane BL.

Risk Anal. 2005 Jun;25(3):543-53.

PMID:
16022689
16.

Unexplained high AST in locally advanced breast cancer.

Birtle A, Lawton P, Chaundary M, Richman P, Mcfarlane B.

Breast J. 2003 Nov-Dec;9(6):505-6. No abstract available.

PMID:
14616949
17.

Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease.

Gregorio GV, McFarlane B, Bracken P, Vergani D, Mieli-Vergani G.

Autoimmunity. 2002 Dec;35(8):515-9.

PMID:
12765477
18.

Specific liver autoreactivity in schistosomiasis mansoni.

Pereira LM, McFarlane BM, Massarolo P, Saleh MG, Bridger C, Spinelli V, Mies S, McFarlane IG.

Trans R Soc Trop Med Hyg. 1997 May-Jun;91(3):310-4.

PMID:
9231205
19.

Alcohol dehydrogenase: a target of humoral autoimmune response in liver disease.

Ma Y, Gäken J, McFarlane BM, Foss Y, Farzaneh F, McFarlane IG, Mieli-Vergani G, Vergani D.

Gastroenterology. 1997 Feb;112(2):483-92.

PMID:
9024302
20.
21.

Autoimmune mechanisms in chronic hepatitis B and delta virus infections.

McFarlane BM, Bridger CB, Smith HM, Antonov KA, Naoumov N, Williams R, McFarlane IG.

Eur J Gastroenterol Hepatol. 1995 Jul;7(7):615-21.

PMID:
8590155
22.

Antibody-directed complement-mediated cytotoxicity to hepatocytes from patients with chronic hepatitis B.

Michalak TI, Lau JY, McFarlane BM, Alexander GJ, Eddleston AL, Williams R.

Clin Exp Immunol. 1995 May;100(2):227-32.

23.

Antibodies to atypical mycobacteria in primary biliary cirrhosis.

O'Donohue J, McFarlane B, Bomford A, Yates M, Williams R.

J Hepatol. 1994 Nov;21(5):887-9.

PMID:
7890908
24.

Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C.

Koskinas J, McFarlane BM, Nouri-Aria KT, Tibbs CJ, Mizokami M, Donaldson PT, McFarlane IG, Williams R.

Gastroenterology. 1994 Nov;107(5):1436-42.

PMID:
7523226
25.

Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis.

Treichel U, McFarlane BM, Seki T, Krawitt EL, Alessi N, Stickel F, McFarlane IG, Kiyosawa K, Furuta S, Freni MA, et al.

Gastroenterology. 1994 Sep;107(3):799-804.

PMID:
8076767
26.

Virus-induced autoimmunity in hepatitis C virus infections: a rare event.

McFarlane BM, Bridger C, Tibbs CJ, Saleh MG, Fuzio A, Verucchi G, Attard L, Boschi A, Chiodo F, McFarlane IG, et al.

J Med Virol. 1994 Jan;42(1):66-72.

PMID:
7508490
27.

Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity.

Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, Vergani D, Bianchi FB, Williams R.

Lancet. 1991 Aug 3;338(8762):277-80.

PMID:
1677111
28.

Anti-asialoglycoprotein receptor antibody and intestinal-origin alkaline phosphatase in plasma in diabetes.

Rosalki SB, Kuwana T, McFarlane BM, McFarlane IG.

Clin Chem. 1991 Apr;37(4):589. No abstract available.

PMID:
2015684
29.

T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis.

Wen L, Peakman M, Lobo-Yeo A, McFarlane BM, Mowat AP, Mieli-Vergani G, Vergani D.

Lancet. 1990 Dec 22-29;336(8730):1527-30.

PMID:
1979365
30.

Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies.

Johnson PJ, McFarlane IG, McFarlane BM, Williams R.

J Gastroenterol Hepatol. 1990 May-Jun;5(3):244-51.

PMID:
2103405
31.

Antibodies against the hepatic asialoglycoprotein receptor perfused in situ preferentially attach to periportal liver cells in the rat.

McFarlane BM, Sipos J, Gove CD, McFarlane IG, Williams R.

Hepatology. 1990 Mar;11(3):408-15.

PMID:
2312054
32.

Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.

Bedlow AJ, Donaldson PT, McFarlane BM, Lombard M, McFarlane IG, Williams R.

J Clin Lab Immunol. 1989 Nov;30(3):103-9.

PMID:
2642168
33.

Immunohistochemical demonstration of the asialoglycoprotein receptor in rat liver by a sensitive avidin-biotin technique.

Sipos J, McFarlane BM, McSorley CG, Gove CD, Williams R, McFarlane IG.

J Pathol. 1989 Jul;158(3):247-52.

PMID:
2671324
34.

Detection of anti-liver cell membrane antibody using a human hepatocellular carcinoma cell line.

Lobo-Yeo A, McSorley C, McFarlane BM, Mieli-Vergani G, Mowat AP, Vergani D.

Hepatology. 1989 Feb;9(2):210-4.

PMID:
2536348
35.

Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood.

Mieli-Vergani G, Lobo-Yeo A, McFarlane BM, McFarlane IG, Mowat AP, Vergani D.

Hepatology. 1989 Feb;9(2):198-203.

PMID:
2521474
36.

Production of murine monoclonal antibodies against a liver-specific, species cross-reactive antigen in the liver-specific lipoprotein (LSP) preparation.

McSorley CG, Isaac JE, McFarlane BM, McFarlane IG, Williams R.

J Immunol Methods. 1988 Nov 10;114(1-2):161-6.

PMID:
2460561
37.

Sensitive avidin biotin based technique for identifying liver membrane antigens in tissue sections.

Sipos J, McFarlane BM, Williams R, McFarlane IG.

J Clin Pathol. 1988 Nov;41(11):1217-22.

38.

Serial study of liver-directed autoantibodies and autoreactive T-lymphocytes in acute viral hepatitis B.

Vento S, McFarlane BM, Vento TG, Ranieri S, Rondanelli EG, McFarlane IG, Williams R, Eddleston AL.

J Autoimmun. 1988 Jun;1(3):299-307.

PMID:
3075130
39.

Liver autoreactivity in acute virus A, B and non-A, non-B hepatitis.

Vento S, McFarlane BM, McSorley CG, Ranieri S, Giuliani-Piccari G, Dal Monte PR, Verucchi G, Williams R, Chiodo F, McFarlane IG.

J Clin Lab Immunol. 1988 Jan;25(1):1-7.

PMID:
3133482
41.

Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders.

McFarlane BM, McSorley CG, Vergani D, McFarlane IG, Williams R.

J Hepatol. 1986;3(2):196-205.

PMID:
3794301
42.

Species cross-reactivity of anti-LSP antibodies in acute viral hepatitis.

Perperas A, McFarlane BM, McSorley CG, McFarlane IG, Williams R.

J Clin Lab Immunol. 1986 Jan;19(1):25-30.

PMID:
2422379
43.

A radioimmunoassay for detection of circulating antibodies reacting with the hepatic asialoglycoprotein receptor protein.

McFarlane BM, McSorley CG, McFarlane IG, Williams R.

J Immunol Methods. 1985 Mar 18;77(2):219-28.

PMID:
3981001
44.

Twenty-five years on. Interview by Harriet Gaze.

McFarlane B.

Nurs Times. 1984 Dec 19-1985 Jan 1;80(51):18-9. No abstract available.

PMID:
6570015
45.

Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis.

McFarlane IG, Hegarty JE, McSorley CG, McFarlane BM, Williams R.

Lancet. 1984 Oct 27;2(8409):954-6.

PMID:
6149344
46.

Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP).

McFarlane IG, McFarlane BM, Major GN, Tolley P, Williams R.

Clin Exp Immunol. 1984 Feb;55(2):347-54.

47.

Development of a micro enzyme-linked immunosorbent assay for antibodies against liver-specific membrane lipoprotein.

McFarlane IG, Tolley P, Major G, McFarlane BM, Williams R.

J Immunol Methods. 1983 Nov 11;64(1-2):215-25.

PMID:
6358364
48.
49.

Antibodies to the California group of arboviruses in animal populations of New Brunswick.

McFarlane BL, Embree JE, Embil JA, Rozee KR, Artsob A.

Can J Microbiol. 1982 Feb;28(2):200-4.

PMID:
7066765
50.

Antibodies to snowshoe hare virus of the California group in the snowshoe hare (Lepus americanus) and domestic animal populations of Prince Edward Island.

McFarlane BL, Embree JE, Embil JA, Artsob H, Weste JB, Rozee KR.

Can J Microbiol. 1981 Nov;27(11):1224-7.

PMID:
7317860

Supplemental Content

Loading ...
Support Center